Zithromax, Azithromycin

Zithromax, Azithromycin Newswire (Page 7)

Comprehensive Real-Time News Feed for Zithromax, Azithromycin (generic). (Page 7)

Results 121 - 140 of 172 in Zithromax, Azithromycin (generic)

  1. Diarrhea and candidiasis associated with common antibiotic amoxicillinRead the original story w/Photo

    Nov 17, 2014 | PhysOrg Weblog

    Diarrhea and candidiasis can result from taking the common antibiotic treatments, amoxicillin and amoxicillin-clavulanic acid, although harms may be underreported, according to a study published in CMAJ . Amoxicillin is the most commonly prescribed antibiotic for respiratory infections by primary care physicians, and is often prescribed in combination with clavulanic acid.

    Comment?

  2. You might be allergic to penicillin; then again, you might notRead the original story w/Photo

    Nov 7, 2014 | Science Daily

    Many people have been told, incorrectly, that they're allergic to penicillin, but have not had allergy testing. These people are often given alternative antibiotics prior to surgery to ward off infection.

    Comment?

  3. Oki Marines fall ill after training in murky watersRead the original story w/Photo

    Nov 3, 2014 | MilitaryCity.com

    Corps officials have closed off a portion of the jungle warfare training center in Okinawa, Japan, thought to be contaminated with a bacteria that has left dozens of Marines sick. Over the past two months, about 90 Marines are suspected to have contracted a rare illness called leptospirosis, which can turn serious if left untreated.

    Comment?

  4. Bad breath/post-nasal drip - what's causing this?Read the original story w/Photo

    Nov 2, 2014 | Ask MetaFilter

    A few months ago I had a cough, runny nose, light sore throat, and feeling like my sinuses were sending nasty stuff in to my throat. I eventually took a 5-day course of azithromycin for it , and it knocked most of it down.

    Comment?

  5. Do you need antibiotics?Read the original story w/Photo

    Nov 2, 2014 | Fox News

    But despite what you may think, the best way to feel better may not be through antibiotics. These meds fight bacteria, so if those nasty bugs aren't what's making you sick, taking antibiotics won't actually do a damn thing.

    Comment?

  6. InSite Vision to Report Third Quarter 2014 Financial Results on November 5, 2014Read the original story

    Oct 29, 2014 | Freshnews

    InSite Vision Incorporated announced that it will report financial results for the quarter ended September 30, 2014 on Wednesday, November 5, 2014. InSite Vision management will host a conference call that day beginning at 4:30 p.m. ET/1:30 p.m. PT to discuss third quarter 2014 financial results and to review recent accomplishments and upcoming milestones.

    Comment?

  7. Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals.Read the original story

    Oct 28, 2014 | CiteULike

    Significant quantities of antibiotics are used in all parts of the globe to treat diseases with bacterial origins. After ingestion, antibiotics are excreted by the patient and transmitted in due course to the aquatic environment.

    Comment?

  8. Sequence selectivity of macrolide-induced translational attenuationRead the original story

    Oct 24, 2014 | CiteULike

    The prevailing "plug-in-the-bottle" model suggests that macrolide antibiotics inhibit translation by binding inside the ribosome tunnel and indiscriminately arresting the elongation of every nascent polypeptide after the synthesis of six to eight amino acids. To test this model, we performed a genome-wide analysis of translation in azithromycin-treated Staphylococcus aureus.

    Comment?

  9. Just Published: "Nexchem Pharmaceutical Co., Ltd. - Pharmaceuticals & ...Read the original story

    Oct 18, 2014 | PR-inside.com

    The company carries out research, production and sale of active pharmaceutical ingredients. Its products include alizapride, 1,3-cyclohexanedione, azithromycin dihydrate, water-soluble azithromycin, levosulpiride, azithromycin bitterless, clarithromycin, clarithromycin enteric coated granules, roxithromycin, meropenem for injection, meropenem, fenofibrate, glimepiride, benserazide hydrochloride, and fleroxacin.

    Comment?

  10. Notes from the Field: Increase in Gonorrhea Cases in Counties...Read the original story

    Oct 16, 2014 | Centers for Disease Control and Prevention

    Notes from the Field: Increase in Gonorrhea Cases in Counties Associated with American Indian Reservations - Montana, January 2012-August 2014 In May 2012, the Montana Department of Public Health and Human Services noted that 23 cases of gonorrhea were reported in Roosevelt County during October 2011-March 2012, compared with only three cases during January-September 2011.

    Comment?

  11. Does Digoxin Really Increase Mortality Among Outpatients With Atrial Fibrillation?Read the original story

    Oct 15, 2014 | Pharmacy Times

    Craig Cocchio, PharmD, is a clinical assistant professor and clinical pharmacist specializing in emergency medicine at Rutgers University and Robert Wood Johnson University Hospital in New Brunswick, New Jersey. Dr. Cocchio is also the creator, editor-in-chief, and blogger at the EM PharmD Blog which focuses on emergency medicine from the perspective of the pharmacist.

    Comment?

  12. On The Fly: Analyst Downgrade SummaryRead the original story

    Oct 1, 2014 | Theflyonthewall.com

    Durata Therapeutics granted SPA by FDA for DALVANCE Phase 3 study Durata Therapeutics announced that the company has received a Special Protocol Agreement, or SPA, from the FDA on the design of its Phase 3 study of DALVANCE for injection using a 1500 mg single dose for the treatment of patients with community-acquired pneumonia requiring intravenous therapy. The study is designed to compare a 1500 mg single IV dose of dalbavancin with linezolid; patients randomized to linezolid can switch to oral therapy after an initial period of IV treatment.

    Comment?

  13. Listen now or download MP3Read the original story w/Photo

    Oct 9, 2014 | Centers for Disease Control and Prevention

    Listen to/view CDC podcasts on your computer or download them for reliable health and safety information when and where you want it. New to podcasting? See Podcast Help and RSS Help Dr. Mike Miller reads an abridged version of the article, Dengue Virus Transmission by Blood Stem Cell Donor after Travel to Sri Lanka; Germany, 2013.

    Comment?

  14. Randomized trial examines community-acquired pneumonia treatmentsRead the original story w/Photo

    Oct 6, 2014 | PhysOrg Weblog

    In a randomized clinical trial of antibiotic treatments for community-acquired pneumonia , researchers did not find that monotherapy with I2-lactam alone was worse than a combination therapy with a macrolide in patients hospitalized with moderately severe pneumonia, write author Nicolas Garin, M.D., HA pital Riviera-Chablais, Switzerland, and colleagues. CAP is responsible for a high burden of deaths, hospitalizations and health care costs .

    Comment?

  15. Chlamydia: Symptoms, Treatment and PreventionRead the original story w/Photo

    Oct 6, 2014 | Live Science

    Though it's one of the most common and curable sexually transmitted diseases in both genders, chlamydia is often symptomless and goes untreated. When it does, the consequences in women can be particularly severe, resulting in chronic pelvic pain or infertility.

    Comment?

  16. FDA Grants Durata Therapeutics, Inc. A Special Protocol Agreement...Read the original story

    Oct 3, 2014 | BioSpace

    Durata Therapeutics today announced that the Company has received a Special Protocol Agreement from the Food and Drug Administration on the design of its Phase 3 study of DALVANCE for injection using a 1500 mg single dose for the treatment of patients with community-acquired pneumonia requiring intravenous therapy. The study is designed to compare a 1500 mg single IV dose of dalbavancin with linezolid; patients randomized to linezolid can switch to oral therapy after an initial period of IV treatment.

    Comment?

  17. FDA clears protocol for single dose Dalvance Phase 3Read the original story w/Photo

    Oct 3, 2014 | Seeking Alpha

    The FDA approves the Phase 3 clinical trial protocol for Durata Therapeutics' Dalvance . The study design will compare a single 1500 mg IV dose of dalbavancin to linezolid .

    Comment?

  18. Durata Therapeutics granted SPA by FDA for DALVANCE Phase 3 studyRead the original story

    Oct 3, 2014 | Theflyonthewall.com

    Durata Therapeutics granted SPA by FDA for DALVANCE Phase 3 study Durata Therapeutics announced that the company has received a Special Protocol Agreement, or SPA, from the FDA on the design of its Phase 3 study of DALVANCE for injection using a 1500 mg single dose for the treatment of patients with community-acquired pneumonia requiring intravenous therapy. The study is designed to compare a 1500 mg single IV dose of dalbavancin with linezolid; patients randomized to linezolid can switch to oral therapy after an initial period of IV treatment.

    Comment?

  19. FDA Grants Durata Therapeutics a Special Protocol Agreement (SPA) for ...Read the original story w/Photo

    Oct 3, 2014 | GlobeNewswire

    Durata Therapeutics today announced that the Company has received a Special Protocol Agreement from the Food and Drug Administration on the design of its Phase 3 study of DALVANCE for injection using a 1500 mg single dose for the treatment of patients with community-acquired pneumonia requiring intravenous therapy. The study is designed to compare a 1500 mg single IV dose of dalbavancin with linezolid; patients randomized to linezolid can switch to oral therapy after an initial period of IV treatment.

    Comment?

  20. Management and prevention of exacerbations of COPD.Read the original story

    Oct 2, 2014 | CiteULike

    Patients with chronic obstructive pulmonary disease are prone to acute respiratory exacerbations, which can develop suddenly or subacutely over the course of several days. Exacerbations have a detrimental effect on patients' health status and increase the burden on the healthcare system.

    Comment?